Alector (ALEC) Change in Account Payables (2018 - 2026)
Alector (ALEC) posted quarterly Change in Account Payables of -$268000.0 for Q1 2026, down 341.44% year-over-year from $111000.0 in Q1 2025, and up 91.26% quarter-over-quarter from -$3.1 million in Q4 2025.
Alector (ALEC) Change in Account Payables (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Change in Account Payables for 9 consecutive years, with -$268000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 341.44% year-over-year to -$268000.0; the TTM figure through Mar 2026 stood at -$903000.0 (up 59.83% YoY), while the FY2025 annual figure was -$524000.0, up 63.64% from the prior year.
- Change in Account Payables rose to -$268000.0 in Q1 2026 per ALEC's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.5 million in Q3 2025 and bottomed at -$3.1 million in Q4 2025.
- Historically, Change in Account Payables has averaged -$187176.5 across 5 years, with a median of -$109000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Account Payables tumbled 437.04% — and 2024, when it soared 17150.0%.
- Alector's Change in Account Payables stood at -$189000.0 in 2022, then sank by 437.04% to -$1.0 million in 2023, then plunged by 173.3% to -$2.8 million in 2024, then slipped by 10.53% to -$3.1 million in 2025, then surged by 91.26% to -$268000.0 in 2026.
- Business Quant data shows ALEC's Change in Account Payables at -$268000.0 in Q1 2026, -$3.1 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 860,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 860,000.00 |
| Jun 30, 2026 | 860,000.00 |
| Mar 31, 2026 | -268,000.00 |
| Mar 31, 2026 | -268,000.00 |
| Dec 31, 2025 | -3.07 Mn |
| Dec 31, 2025 | -3.07 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | -109,000.00 |
| Jun 30, 2025 | -109,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Mar 31, 2025 | 111,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 690,000.00 |
| Sep 30, 2024 | 690,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | 918,000.00 |
| Mar 31, 2024 | 918,000.00 |